Document:

Exhibit 10.4

 

FORM OF REGISTRATION RIGHTS AGREEMENT

 

THIS REGISTRATION RIGHTS AGREEMENT
(this “Agreement”), dated as of [●], 2022, is made and entered into by and among Apollomics Inc., a Cayman Islands
exempted company (the “Company”), Maxpro Capital Acquisition Corp., a Delaware corporation (“Maxpro”),
MP One Investment LLC (“Maxpro Sponsor”), a Delaware limited liability company, the executive officers and directors
of Maxpro as of immediately prior to the consummation of the transactions contemplated by the Combination Agreement (as defined below)
(such executive officers and directors, together with Maxpro Sponsor, the “Sponsor Parties”), certain shareholders
of the Company set forth on Exhibit A hereto (the “Apollomics Holders”) (each such Sponsor Party or Apollomics
Holder and any other Person (as defined below) who hereafter becomes a party to this Agreement, each a “Holder”, and,
collectively, the “Holders”).

 

RECITALS

 

WHEREAS, the Company is
party to that certain Business Combination Agreement, dated as of September 14, 2022 (the “Combination
Agreement”), by and among Maxpro, Project Max SPAC Merger Sub, Inc., a Delaware corporation and a wholly-owned
subsidiary of the Company (“Merger Sub”), and the Company, pursuant to which, among other things, on or about the
date hereof, Merger Sub will merge with and into Maxpro, with Maxpro continuing as the surviving entity, in exchange for
Maxpro’s stockholders receiving a right to receive ordinary shares, par value $0.0001 per share, of the Company (the
 “Ordinary Shares”), and, as a result of which, Maxpro will become a wholly-owned subsidiary of the Company and
the Company will become a publicly traded company;

 

WHEREAS, on or about the date
hereof, pursuant to the Combination Agreement, each issued and outstanding security of Maxpro immediately prior to the Effective Time
(as defined in the Combination Agreement) will no longer be outstanding and will automatically be canceled in exchange for a substantially
equivalent security of the Company, all on the terms and conditions set forth in the Combination Agreement;

 

WHEREAS, the Sponsor Parties
and Maxpro are parties to that certain Registration Rights Agreement, dated as of October 7, 2021 (the “Prior Agreement”),
by and among Maxpro, Maxpro Sponsor, and the other Sponsor Parties party thereto;

 

WHEREAS, in connection with
the transactions contemplated by the Combination Agreement, the parties to the Prior Agreement desire to terminate the Prior Agreement
and all rights and obligations created pursuant thereto will be terminated;

 

WHEREAS, in connection with
the Placement Unit Purchase Agreement between Maxpro and Maxpro Sponsor, dated as of October 7, 2021, Maxpro Sponsor acquired 464,150
private placement units of Maxpro, consisting of 464,150 shares of Class A common stock of Maxpro (the “Maxpro Common
Stock”) and 464,150 private placement warrants, each exercisable for one share of Maxpro Common Stock for $11.50 per share
(the “Maxpro Warrants“);

 

WHEREAS, the Sponsor Parties
are acquiring Ordinary Shares (including the Ordinary Shares issued or issuable upon the exercise of any other equity security issued
to the Sponsor Parties pursuant to the terms of the Combination Agreement) on or about the date hereof pursuant to the Combination Agreement;

 

     

     

    

 

WHEREAS, on or about the date
hereof, pursuant to the Combination Agreement, each Maxpro Warrant is automatically and irrevocably modified to provide that such Maxpro
Warrant no longer entitles the holder thereof to exercise such Maxpro Warrant for one share of Maxpro Common Stock for $11.50 per share
and in substitution thereof such Maxpro Warrant shall entitle the holder thereof to exercise such Maxpro Warrant for one Ordinary Share
for $11.50 per share; and

 

WHEREAS, in connection with
the transactions contemplated by the Combination Agreement, the Company and the Holders desire to enter into this Agreement, pursuant
to which the Company shall grant the Holders certain registration rights with respect to certain securities of the Company, as set forth
in this Agreement.

 

NOW, THEREFORE, in consideration
of the representations, covenants and agreements contained herein, and other good and valuable consideration, the receipt and sufficiency
of which are hereby acknowledged, the parties hereto, intending to be legally bound, hereby agree as follows:

 

ARTICLE I

DEFINITIONS

 

Section 1.1      Definitions.
The terms defined in this Article I shall, for all purposes of this Agreement, have the respective meanings set forth below:

 

“Adverse Disclosure”
shall mean any public disclosure of material non-public information, which, in the good faith judgment of the Chief Executive Officer,
the President, such other principal executive officer, the Chief Financial Officer, or the principal financial officer of the Company,
after consultation with counsel to the Company, (a) would be required to be made in any Registration Statement (as defined below)
or Prospectus (as defined below) in order for the applicable Registration Statement or Prospectus not to contain any Misstatement (as
defined below), (b) would not be required to be made at such time but for the filing, effectiveness or continued use of such Registration
Statement or Prospectus, as the case may be, and (c) the Company has (x) a bona fide business purpose for not making such
information public or (y) determined the premature disclosure of such information would materially adversely affect the Company.

 

“Agreement”
shall have the meaning given in the Preamble.

 

“Board”
shall mean the board of directors of the Company.

 

“Claims”
shall have the meaning given in subsection 4.1.1.

 

“Closing Date”
shall mean the date of this Agreement.

 

“Combination Agreement”
shall have the meaning given in the Recitals hereto.

 

    	 	2	 

     

    

 

“Commission”
shall mean the Securities and Exchange Commission.

 

“Company”
shall have the meaning given in the Preamble.

 

“Exchange Act”
shall mean the Securities Exchange Act of 1934, as amended, and the rules and regulations of the Commission promulgated thereunder.

 

“Form F-1 Shelf”
shall have the meaning given in subsection 2.1.1.

 

“Form F-3 Shelf”
shall have the meaning given in subsection 2.1.2.

 

“Holders”
shall have the meaning given in the Preamble hereto.

 

“Lock-Up Period”
means (i) with respect to the Registrable Securities owned by the Sponsor Parties, the “Lock-Up Period” as defined
in the Sponsor Support Agreement and (ii) with respect to any other Holder, the “Lock-Up Period” as defined in the
lock-up agreement with the Company to which such Holder is a party.

 

“Maximum Number of
Securities” shall have the meaning given in subsection 2.1.4.

 

“Maxpro”
shall have the meaning given in the Preamble.

 

“Maxpro Sponsor”
shall have the meaning given in the Recitals.

 

“Maxpro Warrants”
shall have the meaning given in the Recitals.

 

“Minimum Amount”
shall have the meaning given in subsection 2.1.3.

 

“Misstatement”
shall mean an untrue statement of a material fact or an omission to state a material fact required to be stated therein, or necessary
to make the statements therein (in the case of any Prospectus and any preliminary Prospectus, in the light of the circumstances under
which they were made) not misleading.

 

“Ordinary Shares”
shall have the meaning given in the Recitals.

 

“Permitted Transferees”
shall mean a Person to whom the Holders are permitted to transfer Registrable Securities prior to the expiration of the Lock-Up Period
with respect to the Registrable Securities owned by such Holder.

 

“Person”
shall mean any individual, corporation, partnership, limited liability company, association, joint venture, an association, a joint stock
company, trust, unincorporated organization, governmental or political subdivision or agency, or any other entity of whatever nature.

 

“Piggyback Registration”
shall have the meaning given in subsection 2.2.1.

 

“Prior Agreement”
shall have the meaning given in the Recitals hereto.

 

    	 	3	 

     

    

 

“Prospectus”
shall mean the prospectus included in any Registration Statement, as supplemented by any and all prospectus supplements and as amended
by any and all post-effective amendments and including all material incorporated by reference in such prospectus.

 

“Registrable Security”
shall mean (a) any outstanding Ordinary Shares or other equity securities of the Company held by a Holder immediately following
the Closing Date, (b) any Ordinary Shares issued to a Holder pursuant to the terms of the Combination Agreement (including the
Ordinary Shares issued or issuable upon the exercise of any other equity security issued to a Holder pursuant to the terms of the Combination
Agreement), (c) the Maxpro Warrants (including any Ordinary Shares issued or issuable upon the exercise of any Maxpro Warrants)
and (d) any other equity security of the Company issued or issuable with respect to the securities referred to in the foregoing
clauses (a) through (c) by way of a share dividend or share split or in connection with a combination of shares, recapitalization,
merger, consolidation or other reorganization or otherwise; provided, however, that, as to any particular Registrable Security,
such securities shall cease to be Registrable Securities upon the earliest to occur of: (i) a Registration Statement with respect
to the sale of such securities shall have become effective under the Securities Act and such securities shall have been sold, transferred,
disposed of or exchanged in accordance with such Registration Statement by the applicable Holder; (ii) (x) such securities
shall have been otherwise transferred, (y) new certificates for such securities not bearing (or book entry positions not subject
to) a legend restricting further transfer shall have been delivered by the Company to the Holder and (z) subsequent public distribution
of such securities shall not require registration under the Securities Act; (iii) such securities shall have ceased to be outstanding;
(iv) such securities may be sold, transferred, disposed of or exchanged without registration pursuant to Rule 144 promulgated
under the Securities Act (or any successor rule promulgated thereafter by the Commission) (but with no volume or other restrictions
or limitations); and (v) such securities have been sold to, or through, a broker, dealer or underwriter in a public distribution
or other public securities transaction.

 

“Registration”
shall mean a registration effected by preparing and filing a registration statement or similar document in compliance with the requirements
of the Securities Act, and the applicable rules and regulations promulgated thereunder, and such registration statement becoming
effective.

 

“Registration Expenses”
shall mean the documented, out-of-pocket expenses of a Registration, including, without limitation, the following:

 

		(a)	all registration and filing fees (including
                                            fees with respect to filings required to be made with the Financial Industry Regulatory Authority, Inc.)
                                            and any securities exchange on which the Registrable Securities are then listed;

 

		(b)	fees and expenses of compliance with securities
                                            or blue-sky laws (including reasonable fees and disbursements of outside counsel for the
                                            Underwriters (as defined below) in connection with blue sky qualifications of Registrable
                                            Securities);

 

		(c)	printing, messenger, telephone, delivery
                                            and road show or other marketing expenses;

 

    	 	4	 

     

    

 

		(d)	reasonable and documented fees and disbursements
                                            of counsel for the Company;

 

		(e)	reasonable and documented fees and disbursements
                                            of all independent registered public accountants of the Company incurred specifically in
                                            connection with such Registration;

 

		(f)	reasonable and documented fees and expenses
                                            of one (1) legal counsel selected by the Company to render any local counsel opinions
                                            in connection with the applicable Registration; and

 

		(g)	reasonable and documented fees and expenses
                                            of one (1) legal counsel (not to exceed $75,000 in the aggregate for each Registration
                                            without the prior written approval of the Company) selected by (i) the majority-in-interest
                                            of the SUO Demanding Holders (as defined below) initiating a Shelf Underwritten Offering
                                            (as defined below), or (ii) the majority-in-interest of participating Holders under
                                            Section 2.3 if the Registration was initiated by the Company for its own account
                                            or that of a Company shareholder other than pursuant to rights under this Agreement, in each
                                            case to be registered for offer and sale in the applicable Registration.

 

“Registration Statement”
shall mean any registration statement that covers the Registrable Securities pursuant to the provisions of this Agreement, including
the Prospectus included in such registration statement, amendments (including post-effective amendments) and supplements to such registration
statement, and all exhibits to and all material incorporated by reference in such registration statement.

 

“Securities Act”
shall mean the Securities Act of 1933, as amended from time to time, and the rules and regulations of the Commission promulgated
thereunder.

 

“Shelf Takedown Notice”
shall have the meaning given in subsection 2.1.3.

 

“Shelf Underwritten
Offering” shall have the meaning given in subsection 2.1.3.

 

“Sponsor Parties”
shall have the meaning given in the Preamble.

 

“Sponsor Support
Agreement” shall mean that certain Sponsor Support Agreement, dated as of September 14, 2022 (as amended, restated,
supplemented or otherwise modified in accordance with the terms thereto), by and among Maxpro Sponsor, Maxpro, the Company and the
other parties thereto.

 

“SUO Demanding Holders”
shall mean the applicable Holders having the right to make, and actually making, a written demand for a Shelf Underwritten Offering of
Registrable Securities pursuant to subsection 2.1.3.

 

“SUO Requesting Holder”
shall have the meaning given in subsection 2.1.3.

 

    	 	5	 

     

    

 

“Underwriter”
shall mean a securities dealer who purchases any Registrable Securities as principal in an Underwritten Offering and not as part of such
dealer’s market-making activities.

 

“Underwritten Offering”
shall mean a Registration in which securities of the Company are sold to an Underwriter in a firm commitment underwriting for distribution
to the public.

 

“Warrant Agreement”
shall mean that certain Warrant Agreement, dated as of October 7, 2021, by and between Maxpro and Continental Stock Transfer &
Trust Company, as warrant agent.

 

ARTICLE II

REGISTRATIONS

 

Section 2.1      Shelf
Registration.

 

2.1.1            Following
the Closing Date, the Company shall use its commercially reasonable efforts to (i) file a Registration Statement under the Securities
Act within sixty (60) days after the Closing Date to permit the public resale of all the Registrable Securities held by the Holders from
time to time as permitted by Rule 415 under the Securities Act (or any successor or similar provision adopted by the Commission
then in effect) on the terms and conditions specified in this subsection 2.1.1 and (ii) cause such Registration Statement
to be declared effective as soon as practicable after the filing thereof. The Registration Statement filed with the Commission pursuant
to this subsection 2.1.1 shall be a shelf registration statement on Form F-1 (a “Form F-1 Shelf”)
or such other form of registration statement as is then available to effect a registration for resale of such Registrable Securities,
covering such Registrable Securities, and shall contain a Prospectus in such form as to permit any Holder to sell such Registrable Securities
pursuant to Rule 415 under the Securities Act (or any successor or similar provision adopted by the Commission then in effect)
at any time beginning on the effective date for such Registration Statement. A Registration Statement filed pursuant to this subsection
2.1.1 shall provide for the resale pursuant to any method or combination of methods legally available to, and requested by, the Holders.
The Company shall use its commercially reasonable efforts to cause a Registration Statement filed pursuant to this subsection 2.1.1
to remain effective, and to be supplemented and amended to the extent necessary to ensure that such Registration Statement is available
(including to use its commercially reasonable efforts to add Registrable Securities held by Permitted Transferees) or, if not available,
that another Registration Statement is available, for the resale of all the Registrable Securities held by the Holders until all such
Registrable Securities have ceased to be Registrable Securities.

 

2.1.2            The
Company shall use its commercially reasonable efforts to convert the Form F-1 Shelf filed pursuant to subsection 2.1.1 to
a shelf registration statement on Form F-3 (a “Form F-3 Shelf”) as promptly as practicable after the Company
is eligible to use a Form F-3 Shelf and have the Form F-3 Shelf declared effective as promptly as practicable and to cause
such Form F-3 Shelf to remain effective, and to be supplemented and amended to the extent necessary to ensure that such Registration
Statement is available or, if not available, that another Registration Statement is available, for the resale of all the Registrable
Securities held by the Holders until all such Registrable Securities have ceased to be Registrable Securities.

 

    	 	6	 

     

    

 

2.1.3            At
any time and from time to time following the effectiveness of the shelf registration statement required by subsection 2.1.1 or
subsection 2.1.2, any Holder (an “SUO Requesting Holder”) may request to sell all or a portion of their Registrable
Securities in an underwritten offering that is registered pursuant to such shelf registration statement (a “Shelf Underwritten
Offering”); provided that the Company shall only be obligated to effect a Shelf Underwritten Offering if such offering
shall (i) include Registrable Securities proposed to be sold by the SUO Requesting Holder, either individually or together with
other SUO Requesting Holders, with a gross offering price reasonably expected to exceed, in the aggregate, $25 million or (ii) cover
all of the remaining Registrable Securities held by the SUO Demanding Holder, provided that the total offering price is reasonably expected
to exceed $15 million in the aggregate (each of the thresholds described in (i) and (ii), the “Minimum Amount”).
All requests for a Shelf Underwritten Offering shall be made by giving written notice to the Company (the “Shelf Takedown Notice”).
Each Shelf Takedown Notice shall specify the approximate number of Registrable Securities proposed to be sold in the Shelf Underwritten
Offering and the expected price range (net of underwriting discounts and commissions) of such Shelf Underwritten Offering, as well as
the intended method of distribution. Notwithstanding the foregoing, the Company is not obligated to take any action upon receipt of a
Shelf Takedown Notice delivered within ninety (90) days of a prior Shelf Takedown Notice. Upon receipt by the Company of any such written
notification from a SUO Requesting Holder(s) to the Company, subject to the provisions of subsection 2.2.4, the Company
shall include in such Shelf Underwritten Offering all Registrable Securities of such SUO Requesting Holder(s) described in the
Shelf Takedown Notice. The Company shall, together with all participating Holders of Registrable Securities of the Company proposing
(and permitted) to distribute their securities through such Shelf Underwritten Offering, enter into an underwriting agreement in customary
form for such Shelf Underwritten Offering with the managing Underwriter or Underwriters selected by the Company with the approval of
the original SUO Requesting Holder (which shall not be unreasonably withheld, conditioned or delayed). The Company shall not be obligated
to effect more than an aggregate of three (3) Shelf Underwritten Offerings initiated by the Sponsor Parties and an aggregate of
three (3) Shelf Underwritten Offerings initiated by the Apollomics Holders. The SUO Demanding Holders may demand not more than
two (2) Shelf Underwritten Offerings pursuant to this Section 2.1.3 in any twelve (12) month period.

 

2.1.4            If
the managing Underwriter or Underwriters, in good faith, advises the Company, the SUO Demanding Holders and the SUO Requesting Holders,
in writing that, in its opinion, the dollar amount or number of Registrable Securities that the SUO Demanding Holders and the SUO Requesting
Holders desire to sell, taken together with all other Ordinary Shares or other equity securities that the Company desires to sell for
its own account and the Ordinary Shares, if any, as to which a Registration has been requested pursuant to separate written contractual
piggy-back registration rights held by any other stockholders of the Company who desire to sell, exceeds the maximum dollar amount or
maximum number of equity securities that can be sold in such Underwritten Offering without adversely affecting the proposed offering
price, the timing, the distribution method, or the probability of success of such offering (such maximum dollar amount or maximum number
of such securities, as applicable, the “Maximum Number of Securities”), then the Company shall include in such Underwritten
Offering, as follows: (a) first, the Registrable Securities of the SUO Demanding Holders and the SUO Requesting Holders pro rata
based on the number of securities requested to be sold that can be sold without exceeding the Maximum Number of Securities; (b) second,
to the extent that the Maximum Number of Securities has not been reached under the foregoing clause (a), the Ordinary Shares or other
equity securities that the Company desires to sell for its own account, which can be sold without exceeding the Maximum Number of Securities;
and (c) third, to the extent that the Maximum Number of Securities has not been reached under the foregoing clauses (a) and
(b), the Ordinary Shares or other equity securities of other Persons that the Company is obligated to register in a Registration pursuant
to separate written contractual arrangements with such Persons and that can be sold without exceeding the Maximum Number of Securities.

 

    	 	7	 

     

    

 

2.1.5            Withdrawal.
A majority in interest of the SUO Demanding Holders or SUO Requesting Holders initiating a Shelf Underwritten Offering shall have the
right to withdraw its Registrable Securities included in a Shelf Underwritten Offering pursuant to subsection 2.1.3 for any or
no reason whatsoever upon written notification to the Company and the Underwriter or Underwriters (if any) of its intention to so withdraw
at any time up to one business (1) day prior to the filing of the applicable “red herring” prospectus or prospectus
supplement used for marketing such Shelf Underwritten Offering; provided, however, that upon withdrawal of an amount of
Registrable Securities included by the Holders in such Shelf Underwritten Offering, in their capacity as SUO Demanding Holders, being
less than the Minimum Amount, the Company shall cease all efforts to secure effectiveness of the applicable Registration Statement; provided,
further, that a Sponsor Party or an Apollomics Holder may elect to have the Company continue a Shelf Underwritten Offering if
the Minimum Amount would still be satisfied by the Registrable Securities proposed to be sold in the Shelf Underwritten Offering by a
Sponsor Party, an Apollomics Holder or any of their respective Permitted Transferees, as applicable. If withdrawn, a demand for a Shelf
Underwritten Offering shall constitute a demand for a Shelf Underwritten Offering by the withdrawing SUO Demanding Holder for purposes
of Section 2.1.3, unless either (i) such SUO Demanding Holder has not previously withdrawn any Shelf Underwritten
Offering or (ii) such SUO Demanding Holder reimburses the Company for all Registration Expenses with respect to such Shelf Underwritten
Offering (or, if there is more than one SUO Demanding Holder, a pro rata portion of such Registration Expenses based on the respective
number of Registrable Securities that each SUO Demanding Holder has requested be included in such Shelf Underwritten Offering); provided
that, if an SUO Demanding Holder elects to continue a Shelf Underwritten Offering pursuant to the proviso in the immediately preceding
sentence, such Shelf Underwritten Offering shall instead count as a Shelf Underwritten Offering demanded by such Sponsor Party or such
Apollomics Holder, as applicable, for purposes of Section 2.1.3. Following the receipt of any withdrawal notice, the Company
shall promptly forward such withdrawal notice to any other Holders that had elected to participate in such Shelf Underwritten Offering.
Notwithstanding anything to the contrary in this Agreement, the Company shall be responsible for the Registration Expenses incurred in
connection with a Shelf Underwritten Offering prior to its withdrawal under this Section 2.1.5, other than if an SUO Demanding
Holder elects to pay such Registration Expenses pursuant to clause (ii) of the immediately preceding sentence.

 

    	 	8	 

     

    

 

Section 2.2      Piggyback
Registration.

 

2.2.1            Piggyback
Rights. If the Company proposes to file a Registration Statement under the Securities Act with respect to an offering of Ordinary
Shares (including equity securities exercisable or exchangeable for, or convertible into, Ordinary Shares), for its own account or for
the account of stockholders of the Company, other than a Registration Statement (a) filed in connection with any employee share
option or other benefit plan, (b) a Registration Statement on Form F-4 or Form S-8 (or any successor forms), (c) for
an exchange offer or offering of securities solely to the Company’s existing shareholders, (d) for an offering of debt that
is convertible into equity securities of the Company, (e) for a dividend reinvestment plan or similar plans, (f) filed pursuant
to Section 2.1 or (g) filed in connection with any business combination or acquisition involving the Company, then
the Company shall give written notice of such proposed filing to all of the Holders of Registrable Securities as soon as practicable
(but not less than ten (10) days prior to the anticipated filing by the Company with the Commission of any Registration Statement
with respect thereto), which notice shall (A) describe the amount and type of securities to be included in such offering, the intended
method(s) of distribution (including whether such registration will be pursuant to a shelf registration statement), the proposed
date of filing of such Registration Statement with the Commission and the name of the proposed managing Underwriter or Underwriters,
if any, in such offering, in each case to the extent then known, (B) describe such Holders’ rights under this Section 2.2
and (C) offer to all of the Holders of Registrable Securities the opportunity to register the sale of such number of Registrable
Securities as such Holders may request in writing within five (5) days after receipt of such written notice (such Registration
a “Piggyback Registration”). The Company shall, in good faith, cause such Registrable Securities identified in a Holder’s
response notice described in the foregoing sentence to be included in such Piggyback Registration and shall use its commercially reasonable
efforts to cause the managing Underwriter or Underwriters, if any, to permit the Registrable Securities requested by the Holders pursuant
to this subsection 2.2.1 to be included in a Piggyback Registration on the same terms and conditions as any similar securities
of the Company or Company shareholder(s) for whose account the Registration Statement is to be filed included in such Registration
and to permit the sale or other disposition of such Registrable Securities in accordance with the intended method(s) of distribution
thereof. All such Holders proposing to distribute their Registrable Securities through an Underwritten Offering under this subsection
2.2.1, subject to Section 3.3 and Article IV, shall enter into an underwriting agreement in customary form
with the Underwriter(s) selected for such Underwritten Offering by the Company or Company shareholder(s) for whose account
the Registration Statement is to be filed. For purposes of this Section 2.2, the filing by the Company of an automatic shelf
registration statement for offerings pursuant to Rule 415(a) that omits information with respect to any specific offering
pursuant to Rule 430B shall not trigger any notification or participation rights hereunder until such time as the Company amends
or supplements such Registration Statement to include information with respect to a specific offering of Registrable Securities (and
such amendment or supplement shall trigger the notice and participation rights provided for in this Section 2.2).

 

2.2.2            Reduction
of Piggyback Registration. If a Piggyback Registration is to be an Underwritten Offering and the managing Underwriter or Underwriters,
in good faith, advises the Company and the Holders of Registrable Securities participating in the Piggyback Registration in writing that,
in its opinion, the dollar amount or number of the Ordinary Shares or other equity securities that the Company desires to sell, taken
together with (a) the Ordinary Shares or other equity securities, if any, as to which Registration has been demanded pursuant to
separate written contractual arrangements with Persons other than the Holders of Registrable Securities hereunder, (b) the Registrable
Securities as to which registration has been requested pursuant to Section 2.2 hereof, and (c) the Ordinary Shares
or other equity securities, if any, as to which Registration has been requested pursuant to separate written contractual piggy-back registration
rights of other shareholders of the Company, exceeds the Maximum Number of Securities, then:

 

    	 	9	 

     

    

 

2.2.2.1            if
the Registration is undertaken for the Company’s account, the Company shall include in any such Registration (a) first, the
Ordinary Shares or other equity securities that the Company desires to sell for its own account, which can be sold without exceeding
the Maximum Number of Securities; (b) second, to the extent that the Maximum Number of Securities has not been reached under the
foregoing clause (a), the Registrable Securities of Holders exercising their rights to register their Registrable Securities pursuant
to subsection 2.2.1 hereof; and (d) fourth, to the extent that the Maximum Number of Securities has not been reached under the
foregoing clauses (a), (b) and (c), the Ordinary Shares or other equity securities, if any, as to which Registration has been requested
pursuant to written contractual piggy-back registration rights of other shareholders of the Company, which can be sold without exceeding
the Maximum Number of Securities; and

 

2.2.2.2            if
the Registration is pursuant to a request by Persons other than the Holders of Registrable Securities, then the Company shall include
in any such Registration (a) first, the Ordinary Shares or other equity securities, if any, of such requesting Persons, other than
the Holders of Registrable Securities, which can be sold without exceeding the Maximum Number of Securities; the Registrable Securities
of Holders exercising their rights to register their Registrable Securities pursuant to subsection 2.2.1 hereof, pro rata based on the
number of securities requested to be included, which can be sold without exceeding the Maximum Number of Securities; (b) second,
to the extent that the Maximum Number of Securities has not been reached under the foregoing clauses (a) and (b), the Ordinary
Shares or other equity securities that the Company desires to sell for its own account, which can be sold without exceeding the Maximum
Number of Securities; and (c) third, to the extent that the Maximum Number of Securities has not been reached under the foregoing
clauses (a) and (b), the Ordinary Shares or other equity securities other Persons that the Company is obligated to register pursuant
to separate written contractual arrangements with such Persons, which can be sold without exceeding the Maximum Number of Securities.

 

2.2.3            Piggyback
Registration Withdrawal. Any Holder of Registrable Securities shall have the right to withdraw all or any portion of its Registrable
Securities in a Piggyback Registration for any or no reason whatsoever upon written notification to the Company and the Underwriter or
Underwriters (if any) of his, her or its intention to withdraw such Registrable Securities from such Piggyback Registration up to (a) in
the case of a Piggyback Registration not involving an Underwritten Offering or Shelf Underwritten Offering, one (1) day prior to
the effective date of the applicable Registration Statement or (b), in the case of any Piggyback Registration involving an Underwritten
Offering or any Shelf Underwritten Offering, one (1) business day prior to the filing of the applicable “red herring”
prospectus or prospectus supplement with respect to such Piggyback Registration used for marketing such transaction. The Company (whether
on its own good faith determination or as the result of a request for withdrawal by Persons pursuant to separate written contractual
obligations) may withdraw a Registration Statement filed with the Commission in connection with a Piggyback Registration at any time
prior to the effectiveness of such Registration Statement. The Company shall be responsible for the Registration Expenses incurred in
connection with the Piggyback Registration prior to and including its withdrawal under this subsection 2.2.3.

 

    	 	10	 

     

    

 

2.2.4            Unlimited
Piggyback Registration Rights. For purposes of clarity, any Registration effected pursuant to Section 2.2 hereof shall not
be counted as a Registration pursuant to a Shelf Underwritten Offering effected under subsection 2.1.3.

 

Section 2.3      Restrictions
on Registration Rights. If (a) during the period starting with the date sixty (60) days prior to the Company’s good faith
estimate of the date of the filing of, and ending on a date one hundred and twenty (120) days after the effective date of, a Company-initiated
Registration and provided that the Company continues to actively employ, in good faith, all reasonable efforts to cause the applicable
Registration Statement to become effective; (b) the Holders have requested a Shelf Underwritten Offering and the Company and the
Holders are unable to obtain the commitment of underwriters to firmly underwrite the offer; or (c) in the good faith judgment of
the Board such Registration would be seriously detrimental to the Company and the Board concludes as a result that it is essential to
delay the filing of such Registration Statement at such time, the Company shall have the right, upon giving prompt written notice of
such action to the Holders (which notice shall not specify the nature of the event giving rise to such delay or suspension), delay the
filing or initial effectiveness of, or suspend use of, such Registration Statement for the shortest period of time determined in good
faith by the Company to be necessary for such purpose. Notwithstanding anything to the contrary contained in this Agreement, no Registration
shall be required to be effected and no Registration Statement shall be required to become effective, with respect to any Registrable
Securities held by any Holder, until after the expiration of the Lock-Up Period with respect to such Registrable Securities.

 

ARTICLE III

COMPANY PROCEDURES

 

Section 3.1      General
Procedures. If the Company is required to effect the Registration of Registrable Securities, the Company shall use its commercially
reasonable efforts to effect such Registration to permit the sale of such Registrable Securities in accordance with the intended plan
of distribution thereof, and pursuant thereto the Company shall, as expeditiously as reasonably possible:

 

3.1.1            prepare
and file with the Commission a Registration Statement with respect to such Registrable Securities and use its commercially reasonable
efforts to cause such Registration Statement to become effective and remain effective until all Registrable Securities covered by such
Registration Statement are sold in accordance with the intended plan of distribution set forth in such Registration Statement or have
ceased to be Registrable Securities;

 

3.1.2            prepare
and file with the Commission such amendments and post-effective amendments to the Registration Statement, and such supplements to the
Prospectus, as may be reasonably requested by any Holder that holds at least five percent of the Registrable Securities registered on
such Registration Statement or any Underwriter of Registrable Securities or as may be required by the rules, regulations or instructions
applicable to the registration form used by the Company or by the Securities Act or rules and regulations thereunder to keep the
Registration Statement effective until all Registrable Securities covered by such Registration Statement are sold in accordance with
the intended plan of distribution set forth in such Registration Statement or supplement to the Prospectus or have ceased to be Registrable
Securities;

 

    	 	11	 

     

    

 

3.1.3            prior
to filing a Registration Statement or Prospectus, or any amendment or supplement thereto, furnish to the Underwriters, if any, and the
Holders of Registrable Securities included in such Registration, and such Holders’ legal counsel, copies of such Registration Statement
as proposed to be filed, each amendment and supplement to such Registration Statement (in each case including all exhibits thereto and
documents incorporated by reference therein), the Prospectus included in such Registration Statement (including each preliminary Prospectus),
and such other documents as the Underwriters and the Holders of Registrable Securities included in such Registration or the legal counsel
for any such Holders may reasonably request in order to facilitate the disposition of the Registrable Securities owned by such Holders
(provided that the Company shall have no obligation to furnish any documents publicly filed or furnished with the Commission pursuant
to the Electronic Data Gathering, Analysis and Retrieval System (“EDGAR”));

 

3.1.4            prior
to any public offering of Registrable Securities, but in any case no later than the effective date of the applicable Registration Statement,
use its commercially reasonable efforts to (a) register or qualify the Registrable Securities covered by the Registration Statement
under such securities or “blue sky” laws of such jurisdictions in the United States as the Holders of Registrable Securities
included in such Registration Statement (in light of their intended plan of distribution) may request (or provide evidence satisfactory
to such Holders that the Registrable Securities are exempt from such registration or qualification) and (b) take such action necessary
to cause such Registrable Securities covered by the Registration Statement to be registered with or approved by such other governmental
authorities as may be necessary by virtue of the business and operations of the Company or otherwise and do any and all other acts and
things that may be necessary or advisable, in each case, to enable the Holders of Registrable Securities included in such Registration
Statement to consummate the disposition of such Registrable Securities in such jurisdictions; provided, however, that the
Company shall not be required to qualify generally to do business in any jurisdiction where it would not otherwise be required to qualify
or take any action to which it would be subject to general service of process or taxation in any such jurisdiction where it is not then
otherwise so subject;

 

3.1.5            use
its commercially reasonable efforts to cause all such Registrable Securities to be listed on each securities exchange or automated quotation
system on which similar securities issued by the Company are then listed;

 

3.1.6            provide
a transfer agent or warrant agent, as applicable, and registrar for all such Registrable Securities no later than the effective date
of such Registration Statement;

 

3.1.7            advise
each seller of such Registrable Securities, promptly after it shall receive notice or obtain knowledge thereof, of the issuance of any
stop order by the Commission suspending the effectiveness of such Registration Statement or Prospectus the initiation or threatening
of any proceeding for such purpose and promptly use its commercially reasonable efforts to prevent the issuance of any stop order or
to obtain its withdrawal if such stop order should be issued, as applicable;

 

    	 	12	 

     

    

 

3.1.8            notify
the Holders at any time when a Prospectus relating to such Registration Statement is required to be delivered under the Securities Act,
of the happening of any event or the existence of any condition as a result of which the Prospectus included in such Registration Statement,
as then in effect, includes a Misstatement, or in the opinion of counsel for the Company it is necessary to supplement or amend such
Prospectus to comply with law, and then to correct such Misstatement or include such information as is necessary to comply with law,
in each case as set forth in Section 3.4 hereof, at the request of any such Holder promptly prepare and furnish to such
Holder a reasonable number of copies of a supplement to or an amendment of such Prospectus as may be necessary so that, as thereafter
delivered to the purchasers of such securities, such Prospectus shall not include a Misstatement or such Prospectus, as supplemented
or amended, shall comply with law;

 

3.1.9            permit
a representative of the Holders, the Underwriters, if any, and any attorney or accountant retained by such Holders or Underwriter to
participate, at each such Person’s own expense, in the preparation of any Registration Statement, and will cause the Company’s
officers, directors and employees to supply all information reasonably requested by any such representative, Underwriter, attorney or
accountant in connection with the Registration; provided, however, that such representatives or Underwriters enter into
a confidentiality agreement, in form and substance reasonably satisfactory to the Company, prior to the release or disclosure of any
such information;

 

3.1.10          use
its commercially reasonable efforts to obtain a “cold comfort” letter (including a bring-down letter dated as of the date
the Registrable Securities are delivered for sale pursuant to such Registration) from the Company’s independent registered public
accountants in the event of an Underwritten Offering, in customary form and covering such matters of the type customarily covered by
 “cold comfort” letters as the managing Underwriter may reasonably request, and reasonably satisfactory to a majority-in-interest
of the participating Holders and any Underwriter;

 

3.1.11          in
connection with an Underwritten Offering, use commercially reasonable efforts to obtain for the underwriter(s) opinions of counsel
for the Company, covering the matters customarily covered in opinions requested in underwritten offerings and such other matters as may
be reasonably requested by such underwriters;

 

3.1.12          in
the event of any Underwritten Offering, enter into and perform its obligations under an underwriting agreement, in usual and customary
form, with the managing Underwriter of such offering;

 

3.1.13          otherwise
use its commercially reasonable efforts to make available to its security holders, as soon as reasonably practicable, an earnings statement
that satisfies the provisions of Section 11(a) of the Securities Act and the rules and regulations thereunder, including
Rule 158 thereunder (or any successor rule promulgated thereafter by the Commission);

 

3.1.14          with
respect to a Shelf Underwritten Offering, if the Registration involves the Registration of Registrable Securities involving gross proceeds
in excess of $25.0 million, use its commercially reasonable efforts to make available senior executives of the Company to participate
in customary “road show” presentations that may be reasonably requested by the Underwriter in such Underwritten Offering;
and

 

    	 	13	 

     

    

 

3.1.15          otherwise,
in good faith, cooperate reasonably with, and take such customary actions as may reasonably be requested by the participating Holders
consistent with the terms of this Agreement in connection with such Registration.

 

Notwithstanding the foregoing, the Company shall
not be required to provide any documents or information to an Underwriter, broker, sales agent or placement agent if such Underwriter,
broker, sales agent or placement agent has not then been named with respect to the applicable Shelf Underwritten Offering or other offering
involving a registration as an Underwriter, broker, sales agent or placement agent, as applicable.

 

Section 3.2      Registration
Expenses. The Registration Expenses of all Registrations shall be borne by the Company. It is acknowledged by the Holders that the
Holders shall bear all incremental selling expenses relating to the sale of Registrable Securities, such as Underwriters’ commissions
and discounts, brokerage fees, Underwriter marketing costs, stock transfer taxes and, other than as set forth in the definition of “Registration
Expenses,” all reasonable fees and expenses of any legal counsel representing the Holders.

 

Section 3.3      Participation
in Underwritten Offerings.

 

3.3.1            In
connection with any Registration Statement in which a Holder of Registrable Securities is participating, such Holder shall furnish (or
cause to be furnished) to the Company in writing such information and affidavits as the Company reasonably requests for use in connection
with any such Registration Statement or Prospectus (the “Holder Information”). Notwithstanding anything in this Agreement
to the contrary, if any Holder does not provide the Company with its requested Holder Information, the Company may exclude such Holder’s
Registrable Securities from the applicable Registration Statement or Prospectus if the Company determines, based on the advice of counsel,
that it is necessary or advisable to include such information in the applicable Registration Statement or Prospectus and such Holder
continues thereafter to withhold such information. No Person may participate in any Underwritten Offering for equity securities of the
Company pursuant to a Registration initiated pursuant to the terms of this Agreement unless such Person (a) agrees to sell such
Person’s securities on the basis provided in any underwriting, sales, distribution or placement arrangements approved by the Company
and (b) completes and executes all customary questionnaires, powers of attorney, indemnities, lock-up agreements, underwriting
or other agreements and other customary documents as may be reasonably required under the terms of such underwriting, sales or distribution
arrangements. For the avoidance of doubt, the exclusion of a Holder’s Registrable Securities as a result of this Section 3.3.1
shall not affect the Registration of other Registrable Securities to be included in such Registration.

 

3.3.2            The
Company will use its commercially reasonable efforts to ensure that no Underwriter shall require any Holder to make any representations
or warranties to or agreements with the Company or the Underwriters other than representations, warranties or agreements regarding such
Holder and such Holder’s intended method of distribution and any other representation required by law, and if, despite the Company’s
commercially reasonable efforts, an Underwriter requires any Holder to make additional representation or warranties to or agreements
with such Underwriter, such Holder may elect not to participate in such Underwritten Offering (but shall not have any claims against
the Company as a result of such election). Any liability of such Holder to any Underwriter or other Person under such underwriting agreement
shall be limited to an amount equal to the proceeds (net of expenses and underwriting discounts and commissions) that it derives from
such registration.

 

    	 	14	 

     

    

 

Section 3.4      Suspension
of Sales; Adverse Disclosure. Upon receipt of written notice from the Company that a Registration Statement or Prospectus contains
a Misstatement, or in the opinion of counsel for the Company it is necessary to supplement or amend such Prospectus to comply with law,
each of the Holders shall forthwith discontinue disposition of Registrable Securities until it has received copies of a supplemented
or amended Prospectus correcting the Misstatement or including the information counsel for the Company believes to be necessary to comply
with law (it being understood that the Company hereby covenants to prepare and file such supplement or amendment as soon as practicable
after the time of such notice such that the Registration Statement or Prospectus, as so amended or supplemented, as applicable, will
not include a Misstatement and complies with law), or until it is advised in writing by the Company that the use of the Prospectus may
be resumed. If the filing, initial effectiveness or continued use of a Registration Statement in respect of any Registration at any time
would require the Company to make an Adverse Disclosure or would require the inclusion in such Registration Statement of financial statements
that are unavailable to the Company for reasons beyond the Company’s control, the Company may, upon giving prompt written notice
of such action to the Holders (which notice shall not specify the nature of the event giving rise to such delay or suspension), delay
the filing or initial effectiveness of, or suspend use of, such Registration Statement for the shortest period of time, but in no event
more than sixty (60) days, determined in good faith by the Board to be necessary for such purpose. In the event the Company exercises
its rights under the preceding sentence, the Holders agree to suspend, immediately upon their receipt of the notice referred to above,
their use of the Prospectus relating to any Registration in connection with any sale or offer to sell Registrable Securities until such
Holder receives written notice from the Company. The Company shall immediately notify the Holders of the expiration of any period during
which the Company exercised its rights under this Section 3.4. The Holders shall maintain the confidentiality of such notice and
its contents.

 

Section 3.5      Covenants
of the Company. As long as any Holder shall own Registrable Securities, the Company hereby covenants and agrees at all times while
it shall be a reporting company under the Exchange Act, to file timely (or obtain extensions in respect thereof and file within the applicable
grace period) all reports required to be filed by the Company after the date hereof pursuant to Sections 13(a) or 15(d) of
the Exchange Act and to promptly furnish the Holders with true and complete copies of all such filings; provided that any documents publicly
filed or furnished with the Commission pursuant to EDGAR shall be deemed to have been furnished or delivered to the Holders pursuant
to this Section 3.5. The Company further covenants that it shall take such further action as any Holder may reasonably request,
all to the extent required from time to time to enable such Holder to sell Registrable Securities held by such Holder without registration
under the Securities Act within the limitation of the exemptions provided by Rule 144 promulgated under the Securities Act (or
any successor rule promulgated thereafter by the Commission). Upon the request of any Holder, the Company shall deliver to such
Holder a written certification of a duly authorized officer as to whether it has complied with such requirements.

 

    	 	15	 

     

    

 

ARTICLE IV

INDEMNIFICATION AND CONTRIBUTION

 

Section 4.1      Indemnification.

 

4.1.1            The
Company agrees to indemnify, to the extent permitted by law, each Holder of Registrable Securities, its officers, directors and agents
and each Person who controls such Holder (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange
Act) from and against all losses, claims, damages, liabilities and out-of-pocket expenses (including reasonable and documented attorneys’
fees), joint or several (or actions or proceedings, whether commenced or threatened, in respect thereof) (collectively, “Claims”),
to which any such Holder or other Persons may become subject, insofar as such Claims arise out of or are based on any untrue or alleged
untrue statement of any material fact contained in any Registration Statement, Prospectus or preliminary Prospectus or any amendment
thereof or supplement thereto or any omission or alleged omission of a material fact required to be stated therein or necessary to make
the statements therein not misleading; except insofar as the Claim or expense arises out of or is based upon an untrue statement or alleged
untrue statement or omission or alleged omission made in such filing in reliance upon and in conformity with information or affidavit
furnished in writing to the Company by such Holder expressly for use therein.

 

4.1.2            In
connection with any Registration Statement in which a Holder of Registrable Securities is participating pursuant to this Agreement, such
Holder shall furnish (or cause to be furnished) to the Company an undertaking reasonably satisfactory to the Company, to indemnify the
Company, its officers, directors, partners, managers, shareholders, members, employees and agents and each Person who controls the Company
(within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act) from and against any Claims, to
which any the Company or such other Persons may become subject, insofar as such Claims arise out of or are based on any untrue statement
of any material fact contained in the Registration Statement, Prospectus or preliminary Prospectus or any amendment thereof or supplement
thereto or any omission of a material fact required to be stated therein or necessary to make the statements therein not misleading,
but only to the extent that such untrue statement or omission is contained in any information furnished in writing by such Holder expressly
for use therein; provided, however, that the obligation to indemnify shall be several, not joint and several, among such
Holders of Registrable Securities, and the liability of each such Holder of Registrable Securities shall be in proportion to and limited
to the net proceeds received by such Holder from the sale of Registrable Securities pursuant to such Registration Statement. The Holders
of Registrable Securities shall indemnify the Underwriters, their officers, directors and each Person who controls such Underwriters
(within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act) to the same extent as provided
in the foregoing with respect to indemnification of the Company.

 

4.1.3            Any
Person entitled to indemnification herein shall (a) give prompt written notice to the indemnifying party of any Claim with respect
to which it seeks indemnification (provided that the failure to give prompt notice shall not impair any Person’s right to
indemnification hereunder to the extent such failure has not materially prejudiced the indemnifying party) and (b) unless in such
indemnified party’s reasonable judgment a conflict of interest between such indemnified and indemnifying parties may exist with
respect to such Claim, permit such indemnifying party to assume the defense of such Claim with counsel reasonably satisfactory to the
indemnified party. If such defense is assumed, the indemnifying party shall not be subject to any liability for any settlement made by
the indemnified party without its consent (but such consent shall not be unreasonably withheld). An indemnifying party who is not entitled
to, or elects not to, assume the defense of a claim shall not be obligated to pay the fees and expenses of more than one (1) counsel
for all parties indemnified by such indemnifying party with respect to such claim, unless in the reasonable judgment of any indemnified
party a conflict of interest may exist between such indemnified party and any other of such indemnified parties with respect to such
claim. No indemnifying party shall, without the consent of the indemnified party, consent to the entry of any judgment or enter into
any settlement which cannot be settled in all respects by the payment of money (and such money is so paid by the indemnifying party pursuant
to the terms of such settlement) and which settlement includes a statement or admission of fault or culpability on the part of such indemnified
party or does not include as an unconditional term thereof the giving by the claimant or plaintiff to such indemnified party of a release
from all liability in respect to such claim or litigation.

 

    	 	16	 

     

    

 

4.1.4            The
indemnification and contribution provided for under this Agreement (a) shall remain in full force and effect regardless of any
investigation made by or on behalf of the indemnified party or any officer, director or controlling Person of such indemnified party
and shall survive the transfer of Registrable Securities and (b) are not exclusive and shall not limit any rights or remedies which
may be available to any indemnified party at law or in equity or pursuant to any other agreement.

 

4.1.5            If
the indemnification provided under Section 4.1 hereof from the indemnifying party is unavailable or insufficient to hold
harmless an indemnified party in respect of any Claims, then the indemnifying party, in lieu of indemnifying the indemnified party, shall
contribute to the amount paid or payable by the indemnified party as a result of such Claims in such proportion as is appropriate to
reflect the relative fault of the indemnifying party or parties on the other hand in connection with the statements or omissions that
resulted in such Claims, as well as any other relevant equitable considerations; provided, however, that the liability
of any Holder under this subsection 4.1.5 shall be limited to the amount of the net proceeds received by such Holder in such offering
giving rise to such liability. In connection with any Registration Statement, Prospectus or preliminary Prospectus or any amendment thereof
or supplement thereto filed by the Company, the relative fault of the indemnifying party or parties, on the one hand, and the indemnified
party or parties, on the other hand, shall be determined by reference to, among other things, whether any untrue or alleged untrue statement
of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the indemnifying party
or by the indemnified party, and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent
such statement or omission. The amount paid or payable by a party as a result of the losses or other liabilities referred to above shall
be deemed to include, subject to the limitations set forth in subsections 4.1.1, 4.1.2 and 4.1.3 above, any legal
or other fees, charges or out-of-pocket expenses reasonably incurred by such party in connection with any investigation or proceeding.
The parties hereto agree that it would not be just and equitable if contribution pursuant to this subsection 4.1.5 were determined
by pro rata allocation or by any other method of allocation, which does not take account of the equitable considerations referred to
in this subsection 4.1.5. No Person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of
the Securities Act) shall be entitled to contribution pursuant to this subsection 4.1.5 from any Person who was not guilty of
such fraudulent misrepresentation.

 

    	 	17	 

     

    

 

ARTICLE V

MISCELLANEOUS

 

Section 5.1      Notices.
Any notice or communication under this Agreement must be in writing and given by (a) deposit in the United States mail, addressed
to the party to be notified, postage prepaid and registered or certified with return receipt requested, (b) delivery in person
or by courier service providing evidence of delivery, or (c) transmission by hand delivery, electronic mail, telecopy, telegram
or facsimile. Each notice or communication that is mailed, delivered, or transmitted in the manner described above shall be deemed sufficiently
given, served, sent, and received, in the case of mailed notices, on the third business day following the date on which it is mailed
and, in the case of notices delivered by courier service, hand delivery, electronic mail, telecopy, telegram or facsimile, at such time
as it is delivered to the addressee (with the delivery receipt or the affidavit of messenger) or at such time as delivery is refused
by the addressee upon presentation. Any notice or communication under this Agreement must be addressed, if to the Company, to: Apollomics
Inc., 989 E. Hillsdale Blvd, Suite 220, Foster City, CA 94404, Attention: Brianna MacDonald, Senior Vice President, Legal &
General Counsel, with a required copy (which copy shall not constitute notice) to White & Case LLP, 555 Flower Street, Suite 2700,
Los Angeles, CA 90071, Attn: Daniel Nussen, and, if to any Holder, at such Holder’s address or facsimile number as set forth in
the Company’s books and records. Any party may change its address for notice at any time and from time to time by written notice
to the other parties hereto, and such change of address shall become effective thirty (30) days after delivery of such notice as provided
in this Section 5.1.

 

Section 5.2      Assignment;
No Third Party Beneficiaries.

 

5.2.1            This
Agreement and the rights, duties and obligations of the Company hereunder may not be assigned or delegated by the Company in whole or
in part.

 

5.2.2            Prior
to the expiration of the Lock-up Period with respect to the Registrable Securities owned by such Holder, no Holder may assign or delegate
such Holder’s rights, duties or obligations under this Agreement, in whole or in part, except to such Holder’s applicable
Permitted Transferees.

 

5.2.3            This
Agreement and the provisions hereof shall be binding upon and shall inure to the benefit of each of the parties and its successors and
the permitted assigns of the applicable Holders, which shall include Permitted Transferees.

 

5.2.4            This
Agreement shall not confer any rights or benefits on any Persons that are not parties hereto, other than as expressly set forth in this
Agreement and Section 5.2 hereof.

 

5.2.5            No
assignment by any party hereto of such party’s rights, duties and obligations hereunder shall be binding upon or obligate the Company
unless and until the Company shall have received (a) written notice of such assignment as provided in Section 5.1
hereof and (b) the written agreement of the assignee, in a form reasonably satisfactory to the Company, to be bound by the terms
and provisions of this Agreement (which may be accomplished by an addendum or certificate of joinder to this Agreement). Any transfer
or assignment made other than as provided in this Section 5.2 shall be null and void.

 

    	 	18	 

     

    

 

Section 5.3      Severability.
If any portion of this Agreement shall be declared void or unenforceable by any court or administrative body of competent jurisdiction,
such portion shall be deemed severable from the remainder of this Agreement, which shall continue in all respects to be valid and enforceable.

 

Section 5.4      Counterparts.
This Agreement may be executed in multiple counterparts (including facsimile or PDF counterparts), each of which shall be deemed an original,
and all of which together shall constitute the same instrument, but only one of which need be produced. The words “execution,”
 “signed,” “signature,” “delivery” and words of like import in or relating to this Agreement or any
document to be signed in connection with this Agreement shall be deemed to include electronic signatures, deliveries or the keeping of
records in electronic form, each of which shall be of the same legal effect, validity or enforceability as a manually executed signature,
physical delivery thereof or the use of a paper-based recordkeeping system, as the case may be, and the parties hereto consent to conduct
the transactions contemplated hereunder by electronic means.

 

Section 5.5      Governing
Law; Venue; Waiver of Jury Trial. This Agreement, and all claims or causes of action based upon, arising out of, or related to this
Agreement or the transactions contemplated hereby, shall be governed by, and construed in accordance with, the internal laws of the State
of New York. Any action based upon, arising out of or related to this Agreement or the transactions contemplated hereby may only be brought
in the federal courts of the United States of America located in the City of New York, Borough of Manhattan or the courts of the State
of New York, in each case located in the City of New York, Borough of Manhattan, and each of the parties hereto irrevocably submits to
the exclusive jurisdiction of such courts in any such action, waives any objection it may now or hereafter have to personal jurisdiction,
venue or to convenience of forum, agrees that all claims in respect of the action shall be heard and determined only in any such court,
and agrees not to bring any action arising out of or relating to this Agreement or the transactions contemplated hereby in any other
court. Nothing herein contained shall be deemed to affect the right of any party to serve process in any manner permitted by law or to
commence legal proceedings or otherwise proceed against any other party in any other jurisdiction, in each case, to enforce judgments
obtained in any action brought pursuant to this Section 5.5.

 

Section 5.6      EACH
OF THE PARTIES HERETO HEREBY KNOWINGLY, INTENTIONALLY, VOLUNTARILY AND IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN
ANY ACTION BASED UPON, ARISING OUT OF OR RELATED TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY.

 

Section 5.7      Amendments
and Modifications. Upon the written consent of the Company and the Holders of at least a majority-in-interest of the then outstanding
number of Registrable Securities at the time in question, compliance with any of the provisions, covenants and conditions set forth in
this Agreement may be waived, or any of such provisions, covenants or conditions may be amended or modified. No course of dealing between
any Holder or the Company and any other party hereto or any failure or delay on the part of a Holder or the Company in exercising any
rights or remedies under this Agreement shall operate as a waiver of any rights or remedies of any Holder or the Company. No single or
partial exercise of any rights or remedies under this Agreement by a party shall operate as a waiver or preclude the exercise of any
other rights or remedies hereunder or thereunder by such party. No waiver by a party hereto shall be effective unless made in a written
instrument duly executed by the party against whom such waiver is sought to be enforced, and only to the extent set forth in such instrument.

 

    	 	19	 

     

    

 

Section 5.8      Other
Registration Rights. Other than pursuant to the terms of the Warrant Agreement, the Company represents and warrants that no Person,
other than a Holder of Registrable Securities, has any right to require the Company to register any securities of the Company for sale
or to include such securities of the Company in any Registration Statement filed by the Company for the sale of securities for its own
account or for the account of any other Person. Further, the Company represents and warrants that this Agreement supersedes any other
registration rights agreement or agreement with similar terms and conditions among the parties thereto and in the event of a conflict
between any such agreement or agreements and this Agreement, the terms of this Agreement shall prevail.

 

Section 5.9      Prior
Agreement. The Sponsor Parties and Maxpro, as parties to the Prior Agreement, hereby agree that the Prior Agreement is terminated
as of the Closing Date and is replaced in its entirety by this Agreement.

 

Section 5.10    Entire
Agreement. This Agreement (including the documents and the instruments referred to in this Agreement), together with the Combination
Agreement and the Sponsor Support Agreement, constitutes the entire agreement and supersedes all prior agreements and understandings,
both written and oral, between the parties with respect to the subject matter of this Agreement.

 

Section 5.11    Term.
This Agreement shall terminate and be void and of no further force and effect on the earlier of (a) the fifth anniversary of the
date of this Agreement and (b) with respect to any Holder, on the date on which such Holder ceases to hold Registrable Securities
(but in each case in no event prior to the applicable period referred to in Section 4(a)(3) of the Securities Act and Rule 174
thereunder (or any successor rule promulgated thereafter by the Commission)). Further, this Agreement shall terminate and be void
and of no further force and effect upon the mutual written agreement of each of the parties hereto to terminate this Agreement. The provisions
of Article IV shall survive any termination.

 

Section 5.12    Holder
Information. Each Holder agrees, if requested in writing, to represent to the Company the total number of Registrable Securities
held by such Holder in order for the Company to make determinations hereunder.

 

Section 5.13    Additional
Holders; Joinder. In addition to Persons who may be come Holders pursuant to Section 5.2 hereof, subject to the prior
written consent of each of the Sponsor Parties and each of the Apollomics Holders (in each case, so long as such Holder and its affiliates
hold at least three percent of the outstanding Ordinary Shares), the Company may make any Person who acquires Ordinary Shares or rights
to acquire Ordinary Shares after the date hereof a party to this Agreement (each such Person or entity, an “Additional Holder”)
by obtaining an executed joinder to this Agreement from such Additional Holder (a “Joinder”). Such Joinder shall specify
the rights and obligations of the applicable Additional Holder under this Agreement. Upon the execution and delivery and subject to the
terms of a Joinder by such Additional Holder, the Ordinary Shares then owned, or underlying any rights then owned, by such Additional
Holder (the “Additional Holder Ordinary Shares”) shall be Registrable Securities to the extent provided herein and
therein and such Additional Holder shall be a Holder under this Agreement with respect to such Additional Holder Ordinary Shares.

 

Section 5.14    Further
Assurances. From time to time, at another party’s request and without further consideration, each party hereto shall execute
and deliver such additional documents and take all such further action as may be reasonably necessary to consummate the transactions
contemplated by this Agreement.

 

[Signature Pages Follow]

 

    	 	20	 

     

    

 

IN WITNESS WHEREOF, the undersigned
have caused this Agreement to be executed as of the date first written above.

 

	 	COMPANY:
	 	 
	 	APOLLOMICS INC.
	 	 
	 	By:	 
	 	 	Name:
	 	 	Title:

 

[Signature Page to
Registration Rights Agreement]

 

     

     

    

 

	 	MAXPRO:
	 	 
	 	MAXPRO CAPITAL ACQUISITION CORP.
	 	 
	 	By:	 
	 	 	Name:
	 	 	Title:

 

[Signature Page to
Registration Rights Agreement]

 

     

     

    

 

	 	SPONSOR PARTIES:
	 	 
	 	MP ONE INVESTMENT LLC
	 	 
	 	By:	 
	 	 	Name:
	 	 	Title:

 

	 	By:	 
	 	 	Name: Chen, Hong – Jung (Moses)
	 	 
	 	By:	 
	 	 	Name: Song, Yung – Fong (Ron)
	 	 
	 	By:	 
	 	 	Name: Chen, Yi – Kuei (Alex)
	 	 
	 	By:	 
	 	 	Name: Gau, Wey – Chuan (Albert)
	 	 
	 	By:	 
	 	 	Name: Noha Georges
	 	 
	 	By:	 
	 	 	Name: Wu, Soushan

 

[Signature Page to Registration Rights Agreement]

 

     

     

    

 

EXHIBIT A

 

	[●]EX-4.1

 Exhibit 4.1 

WARRANT TO PURCHASE STOCK 

Company: Codiak BioSciences, Inc., a Delaware corporation 

Warrant No. 2022-[     ] 

Number of Shares: [•], subject to adjustment 

Type/Series of Stock: Common Stock, $0.0001 par value per share 

Warrant Price (“Exercise Price”): $1.875 per Share, subject to adjustment 

Issue Date: September [•], 2022 
 Expiration
Date: September [•],
2027                                         
                                         
       See also Section 5.1(b). 
 THIS WARRANT CERTIFIES THAT, for good and
valuable consideration, [•] (together with any successor or permitted assignee or transferee of this warrant to purchase stock (this “Warrant”) or of any shares issued upon exercise hereof,
“Holder”) is entitled to purchase up to the above-stated number of fully paid and non-assessable shares (the “Shares”) of the above-stated Type/Series of Stock
(the “Class”) of the above-named company (the “Company”) at the above-stated Warrant Price, all as set forth above and as adjusted pursuant to Section 2 of this Warrant, subject to the provisions
and upon the terms and conditions set forth in this Warrant. 
 SECTION 1. EXERCISE. 

1.1 Method of Exercise. Holder may at any time and from time to time exercise this Warrant, in whole or in part, by delivering to the
Company the original of this Warrant together with a duly executed Notice of Exercise in substantially the form attached hereto as Appendix 1 and, unless Holder is exercising this Warrant pursuant to a cashless exercise set forth in
Section 1.2, a check, wire transfer of same-day funds (to an account designated by the Company), or other form of payment acceptable to the Company for the aggregate Warrant Price for the Shares being
purchased. Notwithstanding any contrary provision herein, if this Warrant was originally executed and/or delivered electronically, in no event shall Holder be required to surrender or deliver an ink-signed
paper copy of this Warrant in connection with its exercise hereof or of any rights hereunder, nor shall Holder be required to surrender or deliver a paper or other physical copy of this Warrant in connection with any exercise hereof. The Company
shall cause the shares underlying the Warrant (the “Warrant Shares”) purchased hereunder to be transmitted by the Transfer Agent to the Holder by the date that is the earliest of (i) two (2) Trading Days after the
delivery to the Company of the Notice of Exercise and (ii) the number of Trading Days comprising the Standard Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the “Warrant Share Delivery
Date”). Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the
date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days
comprising the Standard Settlement Period following delivery of the Notice of Exercise. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to this section by the Warrant Share Delivery Date, then
the Holder will have the right to rescind such exercise. 
 “Standard Settlement Period” means the standard
settlement period, expressed in a number of Trading Days, on the Company’s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise. 

 “Trading Day” means a day on which the Common Stock is traded on a
Trading Market. 
 1.2 Cashless Exercise. If at the time of exercise hereof there is no effective registration statement registering,
or the prospectus contained therein is not available for the issuance of the Warrant Shares to the Holder, then this Warrant may also be exercised, in whole or in part, at such time by means of a “cashless exercise” in accordance with the
requirements of Section 1.1. Thereupon, the Company shall issue to the Holder such number of fully paid and non-assessable Shares as are computed using the following formula: 

 

					
		 	X = Y(A-B)/A
	 where:
	 		 	
			
		 	X =	 	the number of Shares to be issued to the Holder;
			
		 	Y =	 	the number of Shares with respect to which this Warrant is being exercised (inclusive of the Shares surrendered to the Company in payment of the aggregate Warrant Price);
			
		 	A =	 	the fair market value (as determined pursuant to Section 1.3 below) of one Share; and
			
		 	B =	 	the Warrant Price.

 1.3 Fair Market Value. If shares of the Class are then traded or quoted on a nationally recognized
securities exchange, inter-dealer quotation system or over-the-counter market (a “Trading Market”), the fair market value of a Share shall be the
closing price or last sale price of a share of the Class reported for the Business Day immediately before the date on which Holder delivers this Warrant together with its Notice of Exercise to the Company. If shares of the Class are not
then traded in a Trading Market, the Board of Directors of the Company shall determine the fair market value of a Share in its reasonable good faith judgment. 

1.4 Delivery of Certificate and New Warrant. Within a reasonable time after Holder exercises this Warrant in the manner set forth in
Section 1.1 or 1.2 above, the Company shall deliver to Holder a certificate representing the Shares issued to Holder upon such exercise and, if this Warrant has not been fully exercised and has not expired, a new warrant of like tenor
representing the Shares not so acquired. 
 1.5 Replacement of Warrant. On receipt of evidence reasonably satisfactory to the Company
of the loss, theft, destruction or mutilation of this Warrant and, in the case of loss, theft or destruction, on delivery of an indemnity agreement reasonably satisfactory in form, substance and amount to the Company or, in the case of mutilation,
on surrender of this Warrant to the Company for cancellation, the Company shall, within a reasonable time, execute and deliver to Holder, in lieu of this Warrant, a new warrant of like tenor and amount. 

  
 2 

 1.6 Treatment of Warrant Upon Acquisition of Company. 

(a) Acquisition. For the purpose of this Warrant, “Acquisition” means any transaction or series of related
transactions involving: (i) the sale, lease, exclusive license, or other disposition of all or substantially all of the assets of the Company; (ii) any merger or consolidation of the Company into or with another person or entity (other
than a merger or consolidation effected exclusively to change the Company’s domicile), or any other corporate reorganization, in which the stockholders of the Company in their capacity as such immediately prior to such merger, consolidation or
reorganization, own less than a majority of the Company’s (or the surviving or successor entity’s) outstanding voting power immediately after such merger, consolidation or reorganization (or, if such Company stockholders beneficially own a
majority of the outstanding voting power of the surviving or successor entity as of immediately after such merger, consolidation or reorganization, such surviving or successor entity is not the Company); or (iii) any sale or other transfer by
the stockholders of the Company of shares representing at least a majority of the Company’s then-total outstanding combined voting power. 

(b) Treatment of Warrant at Acquisition. In the event of an Acquisition and if Holder has not exercised this Warrant pursuant to
Section 1 above as to all Shares, then, following such Acquisition, the Holder shall receive upon exercise hereof the kind and amount of securities, cash or other property which the Holder would have been entitled to receive (the
“Alternate Consideration”) pursuant to such Acquisition if such exercise had taken place immediately prior to such Acquisition. In any such case, appropriate adjustment (as determined in good faith by the Board of the
Company) shall be made in the application of the provisions set forth herein with respect to the rights and interests thereafter of the Holder, to the end that the provisions set forth herein (including provisions with respect to changes in and
other adjustments of the Exercise Price) shall thereafter be applicable, as nearly as reasonably may be, in relation to any securities, cash or other property thereafter deliverable upon the exercise of this Warrant. The Company shall not effect any
Acquisition in which the Company is not the surviving entity or the Alternate Consideration includes securities of another entity unless any successor to the Company, surviving entity or other Person (including any purchaser of assets of the
Company) shall assume the obligation to deliver to the Holder such Alternate Consideration as, in accordance with the foregoing provisions, the Holder may be entitled to receive, and the other obligations under this Warrant. Notwithstanding anything
to the contrary, in the event of an Acquisition, the Company or any surviving entity shall, at the Holder’s option, exercisable at any time concurrently with, or within 30 days after, the consummation of the Acquisition (or, if later, the date
of the public announcement of the applicable Acquisition), purchase this Warrant from the Holder by paying to the Holder an amount of cash equal to the Black Scholes Value (as defined below) of the remaining unexercised portion of this Warrant on
the date of the consummation of such Acquisition; provided, however, that, if the Acquisition is not within the Company’s control, including not approved by the Company’s Board of Directors, Holder shall only be entitled to receive from
the Company or any surviving entity the same type or form of consideration (and in the same proportion), at the Black Scholes Value of the unexercised portion of this Warrant, that is being offered and paid to the holders of Common Stock of the
Company in connection with the Acquisition, whether that consideration be in the form of cash, stock or any combination thereof, or whether the holders of Common Stock are given the choice to receive from among alternative forms of consideration in
connection with the Acquisition; provided, further, that if holders of Common Stock of the Company are not offered or paid any consideration in such Acquisition, such holders of Common Stock will be deemed to have received common stock of the
surviving entity (which Entity may be the Company following such Acquisition) in such Acquisition. “Black Scholes Value” means the value of this Warrant based on the Black-Scholes Option Pricing Model obtained from the
“OV” function on Bloomberg determined as of the day of consummation of the applicable Acquisition for pricing purposes and reflecting (A) a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the time
between the date of the public announcement of the applicable Acquisition and the Termination Date, 

  
 3 

 
(B) an expected volatility equal to the greater of 100% and the 100 day volatility obtained from the HVT function on Bloomberg (determined utilizing a 365 day annualization factor) as of the
Trading Day immediately following the public announcement of the applicable Acquisition, (C) the underlying price per share used in such calculation shall be the greater of (i) the sum of the price per share being offered in cash, if any,
plus the value of any non-cash consideration, if any, being offered in such Acquisition and (ii) the highest VWAP during the period beginning on the Trading Day immediately preceding the announcement of
the applicable Acquisition (or the consummation of the applicable Acquisition, if earlier) and ending on the Trading Day of the Holder’s request pursuant to this Section 1.6 and (D) a remaining option time equal to the time between
the date of the public announcement of the applicable Acquisition and the Termination Date and (E) a zero cost of borrow. The payment of the Black Scholes Value will be made by wire transfer of immediately available funds (or such other
consideration) within the later of (i) five Business Days of the Holder’s election and (ii) the date of consummation of the Acquisition. 

SECTION 2. ADJUSTMENTS TO THE SHARES AND WARRANT PRICE. 

2.1 Stock Dividends, Splits, Etc. If the Company declares or pays a dividend or distribution on the outstanding shares of the
Class payable in additional shares of the Class or other securities or property (other than cash), then upon exercise of this Warrant, for each Share acquired, Holder shall receive, without additional cost to Holder, the total number and
kind of securities and property which Holder would have received had Holder owned the Shares of record as of the date the dividend or distribution occurred. If the Company subdivides the outstanding shares of the Class by reclassification or
otherwise into a greater number of shares, the number of Shares purchasable hereunder shall be proportionately increased and the Warrant Price shall be proportionately decreased. If the outstanding shares of the Class are combined or
consolidated, by reclassification or otherwise, into a lesser number of shares, the Warrant Price shall be proportionately increased and the number of Shares shall be proportionately decreased. 

2.2 Reclassification, Exchange, Combinations or Substitution. Upon any event whereby all of the outstanding shares of the
Class are reclassified, exchanged, combined, substituted, or replaced for, into, with or by Company securities of a different class and/or series, then from and after the consummation of such event, this Warrant will be exercisable for the
number, class and series of Company securities that Holder would have received had the Shares been outstanding on and as of the consummation of such event, and subject to further adjustment thereafter from time to time in accordance with the
provisions of this Warrant. The provisions of this Section 2.2 shall similarly apply to successive reclassifications, exchanges, combinations, substitutions, replacements or other similar events. 

2.3 No Fractional Share. No fractional Share shall be issuable upon exercise of this Warrant and the number of Shares to be issued
shall be rounded down to the nearest whole Share. If a fractional Share interest arises upon any exercise of the Warrant, the Company shall eliminate such fractional Share interest by paying Holder in cash the amount computed by multiplying the
fractional interest by (i) the fair market value (as determined in accordance with Section 1.3 above) of a full Share, less (ii) the then-effective Warrant Price. 

2.4 Notice/Certificate as to Adjustments. Upon each adjustment of the Warrant Price, Class and/or number of Shares, the Company,
at the Company’s expense, shall notify Holder in writing within a reasonable time setting forth the adjustments to the Warrant Price, Class and/or number of Shares and facts upon which such adjustment is based. The Company shall, upon
written request from Holder, furnish Holder with a certificate of its Chief Financial Officer, including computations of such adjustment and the Warrant Price, Class and number of Shares in effect upon the date of such adjustment. 

  
 4 

 SECTION 3. REPRESENTATIONS AND COVENANTS OF THE COMPANY. 

3.1 Representations and Warranties. The Company represents and warrants to, and agrees with, the Holder as follows: 

(a) All Shares which may be issued upon the exercise of this Warrant shall, upon issuance, be duly authorized, validly issued, fully paid and non-assessable, and free of any liens and encumbrances except for restrictions on transfer provided for herein or under applicable federal and state securities laws. The Company covenants that it shall at all times
cause to be reserved and kept available out of its authorized and unissued capital stock such number of shares of the Class and other securities as will be sufficient to permit the exercise in full of this Warrant. The Company will take all
such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be
listed. 
 3.2 Notice of Certain Events. If the Company proposes at any time to: 

(a) declare any dividend or distribution upon the outstanding shares of the Class, whether in cash, property, stock, or other securities and
whether or not a regular cash dividend; 
 (b) offer for subscription or sale pro rata to the holders of the outstanding shares of the
Class any additional shares of any class or series of the Company’s stock (other than pursuant to contractual pre-emptive rights); 

(c) effect any reclassification, exchange, combination, substitution, reorganization or recapitalization of the outstanding shares of the
Class; or 
 (d) effect an Acquisition or to liquidate, dissolve or wind up; 

then, in connection with each such event, the Company shall give Holder notice thereof at the same time and in the same manner as it gives notice thereof to
holders of the outstanding shares of the Class. 
 The Company will also provide information requested by Holder from time to time, within a reasonable time
following each such request, that is reasonably necessary to enable Holder to comply with Holder’s accounting or reporting requirements. 

SECTION 4. REPRESENTATIONS, WARRANTIES OF THE HOLDER. 

The Holder represents and warrants to the Company as follows: 

4.1 Purchase for Own Account. This Warrant and the Shares to be acquired upon exercise of this Warrant by Holder are being acquired for
investment for Holder’s account, not as a nominee or agent, and not with a view to the public resale or distribution within the meaning of the Act. Holder also represents that it has not been formed for the specific purpose of acquiring this
Warrant or the Shares. 

  
 5 

 4.2 Disclosure of Information. Holder is aware of the Company’s business affairs
and financial condition and has received or has had full access to all the information it considers necessary or appropriate to make an informed investment decision with respect to the acquisition of this Warrant and its underlying securities.
Holder further has had an opportunity to ask questions and receive answers from the Company regarding the terms and conditions of the offering of this Warrant and its underlying securities and to obtain additional information (to the extent the
Company possessed such information or could acquire it without unreasonable effort or expense) necessary to verify any information furnished to Holder or to which Holder has access. 

4.3 Investment Experience. Holder understands that the purchase of this Warrant and its underlying securities involves substantial
risk. Holder has experience as an investor in securities of companies in the development stage and acknowledges that Holder can bear the economic risk of such Holder’s investment in this Warrant and its underlying securities and has such
knowledge and experience in financial or business matters that Holder is capable of evaluating the merits and risks of its investment in this Warrant and its underlying securities and/or has a preexisting personal or business relationship with the
Company and certain of its officers, directors or controlling persons of a nature and duration that enables Holder to be aware of the character, business acumen and financial circumstances of such persons. 

4.4 No Voting Rights. Holder, as a Holder of this Warrant, will not have any voting rights until the exercise of this Warrant. 

SECTION 5. MISCELLANEOUS. 

5.1 Term. Subject to the provisions of Section 1.6 above, this Warrant is exercisable in whole or in part at any time and from
time to time on or before 6:00 PM, Eastern time, on the Expiration Date and shall be void thereafter. 
 5.2 Notices. All notices and
other communications hereunder from the Company to the Holder, or vice versa, shall be deemed delivered and effective (i) when given personally, (ii) on the third (3rd) Business Day
after being mailed by first-class registered or certified mail, postage prepaid, (iii) upon actual receipt if given by facsimile or electronic mail and such receipt is confirmed in writing by the recipient, or (iv) on the first Business
Day following delivery to a reliable overnight courier service, courier fee prepaid, in any case at such address as may have been furnished to the Company or Holder, as the case may be, in writing by the Company or such Holder from time to time in
accordance with the provisions of this Section 5.2. All notices to Holder shall be addressed as follows until the Company receives notice of a change of address in connection with a transfer or otherwise: 

[•] 
 Attn: [____] 

[Address] 
 Telephone: [____]

 Email address: [____] 

  
 6 

 Notice to the Company shall be addressed as follows until Holder receives notice of a change
in address: 
 Codiak BioSciences, Inc. 

Attn: Douglas E. Williams, Ph.D. 

35 CambridgePark Drive, Suite 500 

Cambridge, Massachusetts 02140 

Telephone: (617) 949-4156 

Email: yalonda.howze@codiakbio.com 

With a copy (which shall not constitute notice) to: 

Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. 

Attn: Megan Gates 
 One
Financial Center 
 Boston, MA 02111 

Telephone: (617) 348-4443 

Email: MGates@mintz.com 

5.3 Amendment and Waiver. This Warrant and any term hereof may be amended or otherwise changed, waived, discharged or terminated
(either generally or in a particular instance and either retroactively or prospectively) only by an instrument in writing signed by the party against which enforcement of such amendment or other change, waiver, discharge or termination is sought.

 5.4 Attorneys’ Fees. In the event of any dispute between the parties concerning the terms and provisions of
this Warrant, the party prevailing in such dispute shall be entitled to collect from the other party all costs incurred in such dispute, including reasonable attorneys’ fees. 

5.5 Counterparts; Facsimile/Electronic Signatures. This Warrant may be executed by one or more of the parties hereto in any number of
separate counterparts, all of which together shall constitute one and the same instrument. The Company, Holder and any other party hereto may execute this Warrant by electronic means and each party hereto recognizes and accepts the use of electronic
signatures and the keeping of records in electronic form by any other party hereto in connection with the execution and storage hereof. To the extent that this Warrant or any agreement subject to the terms hereof or any amendment hereto is executed,
recorded or delivered electronically, it shall be binding to the same extent as though it had been executed on paper with an original ink signature, as provided under applicable law, including, without limitation, any state law based on the Uniform
Electronic Transactions Act. The fact that this Warrant is executed, signed, stored or delivered electronically shall not prevent the transfer by any Holder of this Warrant pursuant to, or the enforcement of, the terms hereof. 

5.6 Headings. The headings in this Warrant are for purposes of reference only and shall not limit or otherwise affect the meaning of
any provision of this Warrant. 
 5.7 Business Days. “Business Day” is any day that is not a Saturday, Sunday
or a day on which The Nasdaq Global Market and commercial banks in the City of New York are closed. 
 SECTION 6. GOVERNING LAW, VENUE,
JURY TRIAL WAIVER, AND JUDICIAL REFERENCE. 
 6.1 Governing Law. This Warrant shall be governed by and construed in accordance
with the laws of the State of New York, without giving effect to its principles regarding conflicts of law. 

  
 7 

 6.2 Jurisdiction and Venue. The Company and Holder each submit to the exclusive
jurisdiction of the state and federal courts in the State of New York; provided, however, that nothing in this Warrant shall be deemed to operate to preclude Holder from bringing suit or taking other legal action in any other jurisdiction to enforce
a judgment or other court order in favor of Holder. The Company expressly submits and consents in advance to such jurisdiction in any action or suit commenced in any such court, and the Company hereby waives any objection that it may have based upon
lack of personal jurisdiction, improper venue, or forum non conveniens and hereby consents to the granting of such legal or equitable relief as is deemed appropriate by such court. The Company hereby waives personal service of the summons,
complaints, and other process issued in such action or suit and agrees that service of such summons, complaints, and other process may be made in accordance with Section 5.2 of this Warrant. 

6.3 Jury Trial Waiver. TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, THE COMPANY AND HOLDER EACH WAIVE THEIR RIGHT TO A JURY
TRIAL OF ANY CLAIM OR CAUSE OF ACTION ARISING OUT OF OR BASED UPON THIS WARRANT, INCLUDING CONTRACT, TORT, BREACH OF DUTY AND ALL OTHER CLAIMS. THIS WAIVER IS A MATERIAL INDUCEMENT FOR THE PARTIES’ AGREEMENT TO THIS WARRANT. EACH PARTY HAS
REVIEWED THIS WAIVER WITH ITS COUNSEL. 
 6.4 Survival. This Section 6 shall survive the termination of this Warrant. 

[Remainder of page left blank intentionally] 

[Signature page follows] 

  
 8 

 IN WITNESS WHEREOF, the parties have caused this Warrant to Purchase Stock to be executed by
their duly authorized representatives effective as of the Issue Date written above. 
  

			
	 “COMPANY”
  

CODIAK BIOSCIENCES, INC.

		
	By:	 	 
	 Name:
 Title:
	 	

  

			
	 “HOLDER”
  

[•]

		
	By:	 	 
	 Name:
 Title:
	 	

  
 9 

 APPENDIX 1 

NOTICE OF EXERCISE 
 1. The
undersigned Holder hereby exercises its right to purchase ___________ shares of the Common Stock of __________________ (the “Company”) in accordance with the attached Warrant To Purchase Stock, and tenders payment of the
aggregate Warrant Price for such shares as follows: 
  

			
	 [    ]
	  	 check in the amount of $________ payable to order of the Company enclosed herewith

		
	 [    ]
	  	 Wire transfer of immediately available funds to the Company’s account

		
	 [    ]
	  	 Cashless Exercise pursuant to Section 1.2 of the Warrant

		
	 [    ]
	  	 Other [Describe] __________________________________________

 2. Please issue a certificate or certificates representing the Shares in the name specified below: 

 

	
	 
	 Holder’s Name

	
	 
	
	 
	 (Address)

 3. By its execution below and for the benefit of the Company, Holder hereby restates each of the
representations and warranties in Section 4 of the Warrant to Purchase Stock as of the date hereof. 
  

			
	 HOLDER:

	
	 
		
	 By:
	 	 
		
	 Name:
	 	 
		
	 Title:
	 	 
		
	 (Date):
	 	 

  
 Schedule 1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00348-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00348-of-00352.parquet"}]]